Thomas, D. (2023). Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock a double-blind, randomized, placebo-controlled trial. Springer.
Chicago Style CitationThomas, Daix. Intravenously Administered Interleukin-7 to Reverse Lymphopenia in Patients With Septic Shock a Double-blind, Randomized, Placebo-controlled Trial. Springer, 2023.
MLA CitationThomas, Daix. Intravenously Administered Interleukin-7 to Reverse Lymphopenia in Patients With Septic Shock a Double-blind, Randomized, Placebo-controlled Trial. Springer, 2023.
Warning: These citations may not always be 100% accurate.